Evidence map›Paper›PMID 31388149›Full record

ArticleNature immunology2019

Publisher Correction: Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.

Marina Cella, Ramya Gamini, Cristiane Sécca, Patrick L Collins, Shanrong Zhao, Vincent Peng, Michelle L Robinette, Jorge Schettini, Konstantin Zaitsev, William Gordon and 14 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. FXR mediates ILC-intrinsic responses to intestinal inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Marina Cella *Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-1230-1313
Ramya Gamini *Pfizer Worldwide Research and Development, Cambridge, MA, USA.
Cristiane SéccaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-4433-8962
Patrick L CollinsDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Shanrong ZhaoPfizer Worldwide Research and Development, Cambridge, MA, USA.
Vincent PengDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Michelle L RobinetteDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-0965-5225
Jorge SchettiniPfizer Worldwide Research and Development, Cambridge, MA, USA.
Konstantin ZaitsevDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0003-3749-0886
William GordonPfizer Worldwide Research and Development, Cambridge, MA, USA.
Jennifer K BandoDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Kentaro YomogidaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Victor CortezDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Catrina FronickThe McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
Robert FultonThe McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
Lih-Ling LinPfizer Worldwide Research and Development, Cambridge, MA, USA.
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Richard A FlavellDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-4461-0778
Liang ShanDepartment of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA.
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Michael BowmanPfizer Worldwide Research and Development, Cambridge, MA, USA.
Eugene M OltzDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Scott A JelinskyPfizer Worldwide Research and Development, Cambridge, MA, USA. Scott.Jelinsky@pfizer.com.ORCID http://orcid.org/0000-0002-5114-0236
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mcolonna@wustl.edu.ORCID http://orcid.org/0000-0001-5222-4987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.